Afifarma is primarily engaged in pharmaceutical preparations activity. Its headquarters is located in Jawa Timur. The company was founded in 1973. Afifarma, officially known as PT Afifarma, was founded by a group of visionary entrepreneurs with a mission to improve healthcare accessibility in Indonesia. The company has grown to become a significant player in the Indonesian pharmaceutical industry, focusing on the production and distribution of high-quality pharmaceutical products. The primary business line of Afifarma is the manufacturing of pharmaceutical preparations, including over-the-counter medications, prescription drugs, and health supplements. The company also engages in secondary activities such as research and development to innovate new healthcare solutions. Afifarma operates several branches across Indonesia, with a strong presence in major cities such as Jakarta, Surabaya, and Bandung. The company's products are distributed nationwide, ensuring a wide geographical footprint within the country. Some of the main product types include antibiotics, analgesics, and vitamins, marketed under well-known brand names that are trusted by healthcare professionals and consumers alike. While Afifarma primarily serves the Indonesian market, it has also begun exploring export opportunities in neighboring Southeast Asian countries, aiming to expand its reach and impact. The company collaborates with various local and international partners to enhance its product offerings and maintain high standards of quality. Afifarma is a member of several pharmaceutical associations, which helps it stay updated with industry trends and regulations. With a commitment to innovation and quality, Afifarma aims to contribute to the betterment of public health and well-being, guided by its vision to be a leading pharmaceutical company in the region.
Headquarters
RT 008, RW 002
Kediri; East Java;
Postal Code: 64131
Contact Details: Purchase the PT Afifarma report to view the information.
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service